<--- Back to Details
First PageDocument Content
Pharmacology / Health / Pharmaceuticals policy / Clinical pharmacology / United States Public Health Service / Abbreviated New Drug Application / Federal Food /  Drug /  and Cosmetic Act / Prescription Drug User Fee Act / Food and Drug Administration / Pharmaceutical sciences / Medicine
Pharmacology
Health
Pharmaceuticals policy
Clinical pharmacology
United States Public Health Service
Abbreviated New Drug Application
Federal Food
Drug
and Cosmetic Act
Prescription Drug User Fee Act
Food and Drug Administration
Pharmaceutical sciences
Medicine

APPENDIX D ALLOWABLE AND EXCLUDED COSTS FOR THE PROCESS FOR THE REVIEW OF ANIMAL DRUG APPLICATIONS The FD&C Act, as amended by ADUFA II, Public Law No[removed], defines the process for the review of animal drug applicati

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 30,91 KB

Share Document on Facebook

Similar Documents

NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

DocID: 1uASt - View Document

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

DocID: 1tBOU - View Document

Smoking / Tobacco control / Health / Food and Drug Administration / Tobacco / Electronic cigarettes / Smoking cessation / Food law / Cigarette / Federal Food /  Drug /  and Cosmetic Act / Premarket tobacco application / Regulation of tobacco by the U.S. Food and Drug Administration

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

DocID: 1roDS - View Document

Food and Drug Administration / Health / Food law / Pharmaceuticals policy / Personal life / Pharmaceutical industry / Healthcare quality / Federal Food /  Drug /  and Cosmetic Act / Medical device / Validation / Center for Devices and Radiological Health / RNA-Seq

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document

Health / Medicine / Medical technology / Food and Drug Administration / Medical device / Medical equipment / Investigational device exemption / Electronic health record / Interoperability / Federal Food /  Drug /  and Cosmetic Act / Interface / Biomedical engineering

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

DocID: 1r7Xt - View Document